Import Biogaia Protectis Baby Drops 5 Ml — Buy in wholesale FOB from Supplier in Poland

Farmacja Warszawska distributes Biogaia Protectis Baby Drops in 5 ml presentation, a probiotic food supplement containing 100 million colony-forming units (CFU) of Limosilactobacillus reuteri DSM 17938 per daily five-drop dose. The formulation uses sunflower oil and medium-chain triglyceride oil (palm kernel oil-derived) as the carrier matrix, designed for oral administration via spoon or food mixing for infants and children aged 0-3 years. Each carton contains 216 bottles, with stated monthly availability of 20,000-30,000 cartons.

The DSM 17938 strain is a well-documented probiotic isolate with published clinical evaluation in infantile colic, regurgitation, and functional gastrointestinal disorders. The oil-based suspension format protects anaerobic viability during shelf life compared to aqueous preparations, though the specific stability data and claimed colony count at end-of-shelf-life are not provided in the listing. The palm kernel oil-derived medium-chain triglyceride component may carry sustainability certification considerations depending on buyer market requirements. The product is classified as a food supplement rather than a medicinal product in most EU jurisdictions, which affects registration, marketing claims, and import classification.

Primary buyers include paediatric product distributors, pharmacy chains, and infant nutrition specialists serving the 0-36 month demographic. The drop format addresses compliance challenges with capsule or sachet probiotic formats for non-solid-food infants. Trade terms require direct negotiation with Farmacja Warszawska: no pricing, MOQ, or standard Incoterms are stated. Buyers should verify current EU health claim regulations for L. reuteri DSM 17938, as authorised claims are strain-specific and jurisdiction-dependent. Cold chain or controlled ambient storage requirements during transport are not specified and must be confirmed.

Farmacja Warszawska operates from Al. Krakowska 110/114, 02-256 Warsaw, in the Mazovia region of Poland, with harbour trust tier indicating partial verification status on the platform. The zero response rate and zero average response hours suggest either new listing activity or inactive account management, so communication reliability should not be assumed. The company profile does not state establishment date, employee count, turnover, warehousing capacity, or pharmaceutical wholesale licence details, so any assessment of operational scale relies on direct inquiry.

The supplier's positioning centres on paediatric probiotic distribution with stated monthly availability figures, though no manufacturing origin is declared, whether the product is sourced directly from BioGaia AB (Sweden) or through authorised regional distribution channels. The address format suggests a commercial premises rather than manufacturing facility. Buyers should verify whether Farmacja Warszawska holds GDP (Good Distribution Practice) certification for pharmaceutical/parapharmaceutical products, and whether their warehouse maintains temperature-mapped storage appropriate for probiotic viability maintenance.